Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.earumpharma.com | |
Market Cap | 38.06 Cr. | |
Enterprise Value(EV) | 40.57 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -0.03 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-12 |
Industry PE | 42.19 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 2.21 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 0.70 | Calculated using Price: 1.54 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 24.71 Cr. | 247,111,618 Shares |
FaceValue | 2 | |
About Murae Organisor Ltd. | ||
The company is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, anti-malarial drugs, anti-allergic & anti cold drugs, analgesic/ anti-pyretic & anti inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastro intestinal drugs, steroids, gynecology drugs, calcium, multivitamins, anti-oxidants and injections. Apart from pharmaceutical formulation products, it also deals in trading of active pharmaceutical ingredients (API's) such as Levofloxacin Hemihdrate IP, Albendazol IP, Amoxicillin Trihydrate IP etc. |
1 Day |
|
-1.91% |
1 Week |
|
-7.23% |
1 Month |
|
+7.69% |
3 Month |
|
-30.94% |
6 Month |
|
+52.48% |
1 Year |
|
-29.36% |
2 Year |
|
-66.00% |
5 Year |
|
|
10 Year |
|
8 years | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 7.15 | 11.05 | 30.94 | 32.17 | 17.83 | 0.61 | 14.24 | 11.18 | |
Return on Capital Employed (%) | 17.1 | 21.97 | 24.94 | 23.99 | 17.4 | 4.23 | 12.34 | 11.66 | |
Return on Assets (%) | 1.11 | 1.61 | 5.98 | 7.77 | 6.11 | 0.28 | 7.85 | 6.91 |
Particulars | 9 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 1 | 2 | 5 | 6 | 14 | 15 | 17 | 19 | 55 | |
Non Curr. Liab. | 0 | 1 | 2 | 3 | 1 | 2 | 0 | 0 | 0 | |
Curr. Liab. | 7 | 9 | 13 | 15 | 20 | 11 | 12 | 10 | 6 | |
Minority Int. | ||||||||||
Equity & Liab. | 9 | 11 | 20 | 23 | 36 | 28 | 29 | 29 | 60 | |
Non Curr. Assets | 0 | 0 | 0 | 0 | 4 | 1 | 1 | 0 | 0 | |
Curr. Assets | 9 | 11 | 19 | 23 | 32 | 27 | 28 | 28 | 60 | |
Misc. Exp. not W/O | ||||||||||
Total Assets | 9 | 11 | 20 | 23 | 36 | 28 | 29 | 29 | 60 |
Particulars | 9 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 19 | 23 | 35 | 51 | 55 | 41 | 21 | 14 | 4 | |
Other Income | 0 | 0 | 0 | 0 | 2 | 9 | 8 | 2 | 1 | |
Total Income | 19 | 24 | 36 | 51 | 57 | 50 | 29 | 16 | 5 | |
Total Expenditure | -18 | -23 | -34 | -47 | -54 | -49 | -25 | -13 | -4 | |
PBIDT | 1 | 1 | 2 | 3 | 4 | 1 | 3 | 3 | 0 | |
Interest | 0 | -1 | -1 | -1 | -1 | -1 | 0 | 0 | 0 | |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Taxation | 0 | 0 | 0 | -1 | -1 | 0 | -1 | -1 | -1 | |
Exceptional Items | ||||||||||
PAT | 0 | 0 | 1 | 2 | 2 | 0 | 2 | 2 | -1 | |
Adjusted EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Particulars | 8 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | -7 | 0 | -3 | -7 | 3 | 0 | |
Cash Fr. Inv. | 0 | 0 | 0 | 0 | -3 | 3 | 0 | ||
Cash Fr. Finan. | 1 | 0 | 7 | 1 | 7 | 3 | -3 | 0 | |
Net Change | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | |
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 |
Mon, 29 Apr 2024
Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Financial Year Ended On 31St March 2024 Compliance Certificate under Regulation 7(3) of SEBI (LODR) Regulations 2015 for the financial year ended on 31st March 2024 |
Sat, 27 Apr 2024
Submission Of Certificate Under Regulation 40(9) Read With Regulation 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Financial Year Ended On 31St March 2024 Submission of Certificate under Regulation 40(9) read with Regulation 40(10) of SEBI (LODR) 2015 for the financial year ended on 31st March 2024 |
Thu, 25 Apr 2024
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report Scrutinizer Report |
Tue, 30 Apr 2024 |
Opening at High |
Opening at Low |
Opening at High for 3 days |
Closing Below Previous Low |
Closing Below Previous Low for 3 days |